Immunogenicity and Safety of Tetravalent Dengue Vaccine (TDV) Co-administered With an Hepatitis A Virus Vaccine
Clinical trial NCT03525119 · COMPLETED
Trial details
- NCT number
- NCT03525119
- Sponsor
- Takeda
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-16
- Primary completion
- 2018-10-03
- Enrollment
- 900
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.